Clinical Trial Update: Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating atezolizumab in patients with cancer following adoptive cell transfer; the study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic and Lymphoid Cell Neoplasm
• Malignant Solid Neoplasm
• Unresectable Malignant Solid Neoplasm

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING